Stereochemical Studies on Medicinal Agents. 10.1 The Role of Chirality in α-Adrenergic Receptor Blockage by (+)- and (-)-Phenoxybenzamine Hydrochloride3

Philip S Portoghese, T. N. Riley, J. W. Miller

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The synthesis and absolute configurational assignment of (+)- and (-)-phenoxybenzamine. HCl (1) were accomplished by utilization of (R)- and (S)-alanine as starting materials, (S)-(+)-1 was 14.5 times more potent than (S)-(-)-1 while the desmethyl analog 2 possessed intermediate αadrenergic blocking activity. Evidence is presented which suggests that the potency difference between enantiomers is due to an affinity difference for the receptor rather than to a difference in intrinsic alkylating capacity. The differences in affinity between (R)-(+ )-1, (S)-( - )-1, and 2 are postulated to be related to the abilities of the aziridinium species derived from these compounds to achieve a negative synclinal conformation and to the binding energy afforded by a properly oriented methyl group.

Original languageEnglish (US)
Pages (from-to)561-564
Number of pages4
JournalJournal of Medicinal Chemistry
Volume14
Issue number7
DOIs
StatePublished - Jul 1 1971

Fingerprint

Phenoxybenzamine
Alanine
Adrenergic Agents
Adrenergic Receptors

Cite this

@article{3ed9342d956a4a7994065f8fc4551968,
title = "Stereochemical Studies on Medicinal Agents. 10.1 The Role of Chirality in α-Adrenergic Receptor Blockage by (+)- and (-)-Phenoxybenzamine Hydrochloride3",
abstract = "The synthesis and absolute configurational assignment of (+)- and (-)-phenoxybenzamine. HCl (1) were accomplished by utilization of (R)- and (S)-alanine as starting materials, (S)-(+)-1 was 14.5 times more potent than (S)-(-)-1 while the desmethyl analog 2 possessed intermediate αadrenergic blocking activity. Evidence is presented which suggests that the potency difference between enantiomers is due to an affinity difference for the receptor rather than to a difference in intrinsic alkylating capacity. The differences in affinity between (R)-(+ )-1, (S)-( - )-1, and 2 are postulated to be related to the abilities of the aziridinium species derived from these compounds to achieve a negative synclinal conformation and to the binding energy afforded by a properly oriented methyl group.",
author = "Portoghese, {Philip S} and Riley, {T. N.} and Miller, {J. W.}",
year = "1971",
month = "7",
day = "1",
doi = "10.1021/jm00289a001",
language = "English (US)",
volume = "14",
pages = "561--564",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Stereochemical Studies on Medicinal Agents. 10.1 The Role of Chirality in α-Adrenergic Receptor Blockage by (+)- and (-)-Phenoxybenzamine Hydrochloride3

AU - Portoghese, Philip S

AU - Riley, T. N.

AU - Miller, J. W.

PY - 1971/7/1

Y1 - 1971/7/1

N2 - The synthesis and absolute configurational assignment of (+)- and (-)-phenoxybenzamine. HCl (1) were accomplished by utilization of (R)- and (S)-alanine as starting materials, (S)-(+)-1 was 14.5 times more potent than (S)-(-)-1 while the desmethyl analog 2 possessed intermediate αadrenergic blocking activity. Evidence is presented which suggests that the potency difference between enantiomers is due to an affinity difference for the receptor rather than to a difference in intrinsic alkylating capacity. The differences in affinity between (R)-(+ )-1, (S)-( - )-1, and 2 are postulated to be related to the abilities of the aziridinium species derived from these compounds to achieve a negative synclinal conformation and to the binding energy afforded by a properly oriented methyl group.

AB - The synthesis and absolute configurational assignment of (+)- and (-)-phenoxybenzamine. HCl (1) were accomplished by utilization of (R)- and (S)-alanine as starting materials, (S)-(+)-1 was 14.5 times more potent than (S)-(-)-1 while the desmethyl analog 2 possessed intermediate αadrenergic blocking activity. Evidence is presented which suggests that the potency difference between enantiomers is due to an affinity difference for the receptor rather than to a difference in intrinsic alkylating capacity. The differences in affinity between (R)-(+ )-1, (S)-( - )-1, and 2 are postulated to be related to the abilities of the aziridinium species derived from these compounds to achieve a negative synclinal conformation and to the binding energy afforded by a properly oriented methyl group.

UR - http://www.scopus.com/inward/record.url?scp=0015090349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015090349&partnerID=8YFLogxK

U2 - 10.1021/jm00289a001

DO - 10.1021/jm00289a001

M3 - Article

VL - 14

SP - 561

EP - 564

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 7

ER -